Bedeutung von Glukosewerten im Krankenhaus

BACKGROUND: Hyperglycemia in people with and without diabetes who are hospitalized is associated with a substantial increase in morbidity, mortality, and health care costs. During hospitalization, metabolic decompensation frequently occurs as a result of various events or adjunctive treatment. Due to the increased risk for an increase in morbidity associated with longer hospital stay as well as higher costs and mortality, a close look at the significance of glucose levels and the forms of therapy in the hospital is warranted. MATERIALS AND METHODS: Current findings, reviews, and basic data were analyzed and the results are summarized and discussed in a brief review. CONCLUSION: Persistent hyperglycemia in the hospital is common and often associated with poor hospital outcomes. Continuous insulin infusion remains the therapy of choice during hyperglycemic crises and critical illness. In noncritically ill patients, insulin also remains the treatment of choice in patients with marked hyperglycemia, high insulin doses already known in outpatients, type 1 diabetes, or patients with steroid-induced hyperglycemia.